The painkillers you can take during chemotherapy depend on your pain level, your specific chemo drugs, and your blood counts. In general, acetaminophen and NSAIDs like ibuprofen are used for mild pain, while opioids are the standard for moderate to severe cancer pain. But none of these are automatically safe during chemo, and each comes with risks that don’t exist for people not on treatment.
Acetaminophen: Often First, but With Caveats
Acetaminophen is typically the first painkiller recommended for mild cancer pain. It’s gentler on the stomach than NSAIDs and doesn’t affect platelet function, which matters when chemo is lowering your blood counts. For bisphosphonate infusions (used to treat cancer that has spread to bone), doctors often recommend taking 650 to 1,000 mg of acetaminophen on the morning of the infusion to blunt the muscle and joint aches that can follow.
The catch is that acetaminophen reduces fever, and fever during chemo can be the only early warning sign of a dangerous infection. When chemotherapy drops your white blood cell count, even a minor infection can become life-threatening. The National Cancer Institute specifically warns that acetaminophen, aspirin, and ibuprofen can all mask signs of a serious problem by suppressing fever. Your oncology team will likely give you a temperature threshold (often 100.4°F) and instructions about when to call, so you need clarity on whether and when to take acetaminophen for general aches versus holding off so you can monitor for fever.
There’s also a drug interaction issue. Certain targeted chemo drugs, including imatinib, dasatinib, and sunitinib, interfere with how your liver processes acetaminophen. This can increase the risk of liver damage. For patients on imatinib specifically, guidelines cap acetaminophen at 1,300 mg per day, well below the 3,000 to 4,000 mg ceiling for healthy adults.
NSAIDs: Effective but Risky for Blood Counts
Nonsteroidal anti-inflammatory drugs, including ibuprofen, naproxen, diclofenac, and celecoxib, reduce both pain and inflammation. They can be used alone for mild pain or combined with opioids for stronger relief. But during chemo, they carry a specific risk that makes many oncologists cautious.
Chemotherapy frequently lowers your platelet count, the cells responsible for clotting. NSAIDs further impair platelet function by thinning the blood, which can lead to excessive bruising or bleeding when counts are already low. The NCI advises cancer patients to avoid over-the-counter medicines containing aspirin or ibuprofen because of this increased bleeding risk, and recommends getting a list of specific products to avoid from your care team.
NSAIDs also interact with certain chemo drugs at the kidney level. They can slow the clearance of methotrexate from your body, prolonging your exposure to the drug and increasing toxicity. Ibuprofen similarly reduces clearance of pemetrexed, another common chemo agent. If you’re on either of these drugs, NSAIDs are likely off the table entirely. For patients who can safely take them, doctors sometimes prefer celecoxib, a type of NSAID that causes fewer stomach and intestinal problems than standard options.
Opioids for Moderate to Severe Pain
For pain rated 4 or higher on a 10-point scale, opioids are the standard treatment for cancer patients. Clinical guidelines from ASCO state that opioids should be offered to patients with moderate to severe cancer-related pain unless there’s a specific reason not to. Morphine is the most commonly used opioid for cancer pain, but options also include oxycodone, hydromorphone, fentanyl, and others.
The typical approach starts with short-acting opioids taken as needed, at the lowest effective dose. If pain persists, the daily dose is increased by 30% to 50% until relief is adequate. When one opioid isn’t working well or causes intolerable side effects, switching to a different one (called opioid rotation) is a standard strategy.
The main side effects of opioids overlap uncomfortably with chemo side effects you may already be dealing with: constipation, nausea, vomiting, and drowsiness. Constipation is nearly universal with opioid use and doesn’t improve over time the way nausea often does. Research supports starting a stimulant laxative like senna when you begin opioid therapy rather than waiting for constipation to develop. Other side effects can include dizziness, dry mouth, difficulty thinking clearly, and in some cases hallucinations or muscle jerks.
Drug interactions matter here too. Targeted therapies like imatinib and nilotinib inhibit the liver enzymes that break down fentanyl, oxycodone, and hydrocodone. This can raise opioid levels in your blood higher than expected, increasing the risk of excessive sedation or respiratory depression. Your oncologist needs to know exactly what pain medications you’re taking so doses can be adjusted.
Nerve Pain Needs Different Treatment
Some chemo drugs, particularly platinum-based agents like oxaliplatin and taxanes like paclitaxel, damage peripheral nerves. This causes tingling, numbness, burning, or shooting pain in the hands and feet. Standard painkillers, including opioids, often don’t work well for this type of pain.
Duloxetine, an antidepressant that also dampens pain signaling, is the only medication with solid clinical evidence supporting its use for established chemo-induced nerve pain. That said, ASCO’s guidelines note the benefit is limited, so expectations should be realistic. Gabapentin and pregabalin are sometimes tried, but multiple clinical trials have failed to show they prevent or meaningfully treat chemo-related nerve pain. ASCO explicitly recommends against using them for prevention.
Other adjuvant medications your team might consider include anticonvulsants, corticosteroids, and topical agents like lidocaine patches. These are typically added alongside other pain medications rather than used alone.
How Pain Management Is Structured
Cancer pain management follows a stepped approach based on severity. For mild pain (rated 1 to 3 out of 10), the starting point is acetaminophen or NSAIDs, sometimes combined with adjuvant medications like antidepressants or anticonvulsants. If you haven’t taken opioids before and your pain is moderate (4 to 7), your team will typically add short-acting opioids on top of those nonopioid options.
For patients already on opioids whose pain isn’t well controlled, the plan shifts to dose adjustments and potentially switching to a different opioid. If pain is severe (8 to 10) at any point, the entire approach gets reassessed, including whether the pain source itself needs to be reevaluated. Bone metastases, nerve compression, or a new problem might need targeted treatment rather than just stronger painkillers.
The key principle running through all of this is that no painkiller during chemo should be taken without your oncology team’s knowledge. Even common over-the-counter medications interact with chemo drugs in ways that can increase toxicity, mask dangerous symptoms, or worsen side effects you’re already managing. Your team can identify which specific painkillers are safe given your regimen, your blood counts, and your liver and kidney function at any given point in treatment.